SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001753926-24-000537
Filing Date
2024-03-15
Accepted
2024-03-15 12:15:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A g084123_13da.htm SC 13D/A 59648
2 EXHIBIT 1 g084123_ex1.htm EX-1 57492
  Complete submission text file 0001753926-24-000537.txt   118644
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Subject) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93847 | Film No.: 24753404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Chancellor Michael B (Filed by) CIK: 0001959360 (see all company filings)

Type: SC 13D/A